NEWS
Events
March 11, 2025
Advancing Hypertension Management: Renal Denervation in clinical practice
Events
March 11, 2025
Ultrasound Renal Denervation is now guideline-recommended: how do I get started?
Did You Know?
March 11, 2025
Sleep disorders, particularly sleep apnea, pose a significant yet often overlooked threat to cardiovascular health. One of the most concerning impacts is their connection to high blood pressure (hypertension).
Research & Publications
March 11, 2025
13 randomized sham-controlled trials (N=2,285) evaluated the efficacy and safety of ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rRDN). uRDN demonstrated a greater reduction in ambulatory SBP across all time points.
Best Practice
March 11, 2025
For three years, Sergiu's life was dominated by extreme high blood pressure – an invisible yet life-threatening burden.
Interview
March 11, 2025
Dr. Karl-Philipp Rommel discusses the renal denervation (RDN) procedure as a treatment for patients with severe, uncontrolled hypertension. RDN is primarily considered for patients whose blood pressure remains high despite multiple medications.
Press Releases
September 3, 2024
The new ESC Guidelines for Management of Elevated Blood Pressure and Hypertension were presented at the ESC Congress in London and reinforce the safety and effectiveness of renal denervation, recommending its consideration as a treatment option to improve uncontrolled hypertension.
Press Releases
November 10, 2023
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States
Press Releases
November 7, 2023
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.
Press Releases
October 26, 2023
Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise™ Ultrasound Renal Denervation system
